Skip to main navigation
Skip to search
Skip to main content
Aston Research Explorer Home
Help & FAQ
Home
Research units
Profiles
Research Outputs
Datasets
Student theses
Activities
Press/Media
Prizes
Equipment
Search by expertise, name or affiliation
Levonorgestrel intrauterine system versus medical therapy for menorrhagia
School of Psychology
Aston Research Centre for Health in Ageing
College of Health and Life Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Levonorgestrel intrauterine system versus medical therapy for menorrhagia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
2-year Follow-up
8%
Abnormal Uterine Bleeding
8%
Activity Score
16%
Attribute Scale
41%
Between-group Difference
16%
Bleeding
8%
Condition-dependent
8%
Confidence Interval
8%
Daily Routines
8%
Emotional Life
8%
Estrogen
8%
Family Life
8%
Family Relationships
8%
General Health-related Quality of Life
8%
Healthcare Workers
8%
Hormonal Treatment
8%
Intervention Engagement
8%
Levonorgestrel-releasing Intrauterine System (LNG-IUS)
100%
Mean Group
8%
Medical Therapy
100%
Medical Treatment
33%
Mefenamic Acid
8%
Menorrhagia
100%
Menstrual Blood Loss
8%
Multi-attribute
41%
Multicenter Randomized Trial
8%
Non-hormonal Treatment
8%
Physical Health
8%
Physical-life
8%
Primary Care Setting
16%
Progesterone
8%
Progestogens
8%
Psychological Health
8%
Quality of Life Domains
8%
Quality of Life Improvement
8%
Related Quality of Life
8%
Scale Domain
8%
Serious Adverse Events
8%
Sexual Behavior
16%
Short-term Benefits
8%
Social Life
16%
Surgical Intervention
16%
Testing Trends
8%
Tranexamic Acid
8%
Treatment as Usual
25%
Treatment Group
8%
Treatment Options
8%
United States
8%
Updated Meta-analysis
8%
Work Routines
8%
Nursing and Health Professions
Adverse Event
9%
Bleeding
9%
Combination Therapy
100%
Confidence Interval
9%
Gestagen
9%
Levonorgestrel
100%
Levonorgestrel Releasing Intrauterine System
100%
Mefenamic Acid
9%
Menorrhagia
100%
Mental Health
9%
Meta Analysis
9%
Primary Medical Care
18%
Progesterone
9%
Quality of Life
36%
Social Life
18%
Surgery
18%
Tranexamic Acid
9%
Treatment Group
9%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
8%
Bleeding
8%
Combination Therapy
100%
Levonorgestrel
100%
Mefenamic Acid
8%
Menorrhagia
100%
Progesterone
8%
Progestin
8%
Tranexamic Acid
8%
Treatment Group
8%
Psychology
Life Domain
25%
Mental Health
25%
Meta-Analysis
25%
Progesterone
25%
Quality of Life
100%
Social Participation
50%
Neuroscience
Levonorgestrel
100%
Mefenamic Acid
8%
Meta-Analysis
8%
Progesterone
8%
Progestin
8%
Tranexamic Acid
8%